MedTrace Logo

Anosmia and / or Ageusia and Early Corticosteroid Use

NCT04528329 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2023-09-06

No results posted yet for this study

Summary

Time to recover of Anosmia and / or ageusia and early corticosteroid use

Conditions

  • Covid19
  • Anosmia

Interventions

DRUG

Early-Dexamethasone

early use of dexamethasone as early as laboratory evidence of high inflammatory markers

DRUG

Late dexamethazone

Use of dexamethasone on deterioration of the cases with increased severity

Sponsors & Collaborators

  • ClinAmygate

    lead OTHER

Principal Investigators

  • Emad R Issak, MD · Assalam Clinics

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-30
Primary Completion
2023-11-01
Completion
2023-12-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04528329 on ClinicalTrials.gov